Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer

Background According to previous literatures, plasma thioredoxin reductase (TrxR) level was significantly elevated in various malignant tumors and serve as a potential biomarker for diagnosis and prognostic prediction. However, there is little awareness of the clinical value of plasma TrxR in gyneco...

Full description

Bibliographic Details
Main Authors: Yinxing Zhu MS, Yixuan Hu MS, Junfeng Shi MD, Xiaowei Wei MD, Yaqi Song MD, Cuiju Tang MD, PhD, Wenwen Zhang MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-06-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338231184995

Similar Items